Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 May;27(5):909–914. doi: 10.1128/jcm.27.5.909-914.1989

Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.

E L Anderson 1, R B Belshe 1, B Burk 1, J Bartram 1, H F Maassab 1
PMCID: PMC267453  PMID: 2745699

Abstract

Twenty-four infants 5 to 13 months of age were intranasally vaccinated with a live cold-recombinant influenza A/Korea (CR-59, H3N2) virus vaccine. Nineteen infants served as controls. The inocula ranged from 10(3.2) to 10(6.2) 50% tissue culture infective doses (TCID50) per infant. Zero of six, one of four, seven of ten, and four of four infants receiving 10(3.2), 10(4.2), 10(5.2), and 10(6.2) TCID50, respectively, were infected by the intranasal vaccine. The amount of virus required to infect 50% of infants was calculated to be 10(4.6) TCID50. The occurrence of fever, respiratory illness, and otitis media was common among both controls and vaccinees in the postinoculation period. Maternal antibody was present in low titers in some infants and did not inhibit replication of the vaccine virus.

Full text

PDF
909

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belshe R. B., Van Voris L. P., Bartram J., Crookshanks F. K. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis. 1984 Dec;150(6):834–840. doi: 10.1093/infdis/150.6.834. [DOI] [PubMed] [Google Scholar]
  2. Belshe R. B., Van Voris L. P. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis. 1984 May;149(5):735–740. doi: 10.1093/infdis/149.5.735. [DOI] [PubMed] [Google Scholar]
  3. Clements M. L., Betts R. F., Maassab H. F., Murphy B. R. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers. J Infect Dis. 1984 May;149(5):814–815. doi: 10.1093/infdis/149.5.814. [DOI] [PubMed] [Google Scholar]
  4. Clements M. L., Murphy B. R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986 Jan;23(1):66–72. doi: 10.1128/jcm.23.1.66-72.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Donabedian A. M., DeBorde D. C., Maassab H. F. Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence. Microb Pathog. 1987 Aug;3(2):97–108. doi: 10.1016/0882-4010(87)90068-4. [DOI] [PubMed] [Google Scholar]
  6. Glezen W. P., Paredes A., Taber L. H. Influenza in children. Relationship to other respiratory agents. JAMA. 1980 Apr 4;243(13):1345–1349. doi: 10.1001/jama.243.13.1345. [DOI] [PubMed] [Google Scholar]
  7. Gorse G. J., Belshe R. B., Munn N. J. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. J Clin Microbiol. 1986 Sep;24(3):336–342. doi: 10.1128/jcm.24.3.336-342.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henderson F. W., Collier A. M., Sanyal M. A., Watkins J. M., Fairclough D. L., Clyde W. A., Jr, Denny F. W. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med. 1982 Jun 10;306(23):1377–1383. doi: 10.1056/NEJM198206103062301. [DOI] [PubMed] [Google Scholar]
  9. Howie V. M., Schwartz R. H. Acute otitis media. One year in general pediatric practice. Am J Dis Child. 1983 Feb;137(2):155–158. [PubMed] [Google Scholar]
  10. Johnson P. R., Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986 Jul;154(1):121–127. doi: 10.1093/infdis/154.1.121. [DOI] [PubMed] [Google Scholar]
  11. Kaplan G. J., Fleshman J. K., Bender T. R., Baum C., Clark P. S. Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics. 1973 Oct;52(4):577–585. [PubMed] [Google Scholar]
  12. Maassab H. F. Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol. 1969 Mar;102(3):728–732. [PubMed] [Google Scholar]
  13. Maassab H. F., DeBorde D. C. Characterization of an influenza A host range mutant. Virology. 1983 Oct 30;130(2):342–350. doi: 10.1016/0042-6822(83)90088-0. [DOI] [PubMed] [Google Scholar]
  14. Maassab H. F., Kendal A. P., Abrams G. D., Monto A. S. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis. 1982 Dec;146(6):780–790. doi: 10.1093/infdis/146.6.780. [DOI] [PubMed] [Google Scholar]
  15. Marchant C. D., Shurin P. A., Turczyk V. A., Wasikowski D. E., Tutihasi M. A., Kinney S. E. Course and outcome of otitis media in early infancy: a prospective study. J Pediatr. 1984 Jun;104(6):826–831. doi: 10.1016/s0022-3476(84)80475-8. [DOI] [PubMed] [Google Scholar]
  16. Murphy B. R., Clements M. L., Madore H. P., Steinberg J., O'Donnell S., Betts R., Demico D., Reichman R. C., Dolin R., Maassab H. F. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May;149(5):816–816. doi: 10.1093/infdis/149.5.816. [DOI] [PubMed] [Google Scholar]
  17. Murphy B. R., Nelson D. L., Wright P. F., Tierney E. L., Phelan M. A., Chanock R. M. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun. 1982 Jun;36(3):1102–1108. doi: 10.1128/iai.36.3.1102-1108.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Murphy B. R., Phelan M. A., Nelson D. L., Yarchoan R., Tierney E. L., Alling D. W., Chanock R. M. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981 Mar;13(3):554–560. doi: 10.1128/jcm.13.3.554-560.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Odagiri T., DeBorde D. C., Maassab H. F. Cold-adapted recombinants of influenza A virus in MDCK cells. I. Development and characterization of A/Ann Arbor/6/60 X A/Alaska/6/77 recombinant viruses. Virology. 1982 May;119(1):82–95. doi: 10.1016/0042-6822(82)90067-8. [DOI] [PubMed] [Google Scholar]
  20. Shurin P. A., Pelton S. I., Donner A., Klein J. O. Persistence of middle-ear effusion after acute otitis media in children. N Engl J Med. 1979 May 17;300(20):1121–1123. doi: 10.1056/NEJM197905173002001. [DOI] [PubMed] [Google Scholar]
  21. Snyder M. H., Clements M. L., Betts R. F., Dolin R., Buckler-White A. J., Tierney E. L., Murphy B. R. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol. 1986 May;23(5):852–857. doi: 10.1128/jcm.23.5.852-857.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wright P. F., Karzon D. T. Live attenuated influenza vaccines. Prog Med Virol. 1987;34:70–88. [PubMed] [Google Scholar]
  23. Wright P. F., Okabe N., McKee K. T., Jr, Maassab H. F., Karzon D. T. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis. 1982 Jul;146(1):71–79. doi: 10.1093/infdis/146.1.71. [DOI] [PubMed] [Google Scholar]
  24. Wright P. F., Ross K. B., Thompson J., Karzon D. T. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med. 1977 Apr 14;296(15):829–834. doi: 10.1056/NEJM197704142961501. [DOI] [PubMed] [Google Scholar]
  25. Wright P. F., Thompson J., Karzon D. T. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol. 1980 Dec;112(6):814–819. doi: 10.1093/oxfordjournals.aje.a113053. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES